ipilimumab · Medicine question

For which adults with renal cell carcinoma is ipilimumab (Yervoy) combined with nivolumab indicated as first-line treatment?

Name: For which adults with renal cell carcinoma is ipilimumab (Yervoy) combined with nivolumab indicated as first-line treatment?
Published: 2026-11-08T01:54:27.202Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Ipilimumab (Yervoy) combined with nivolumab is indicated as first-line treatment for adults with intermediate/poor-risk advanced renal cell carcinoma.

Sources for this answer

YERVOY 5 mg/ml concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 46Document updated 15 July 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about ipilimumab